The trademark application MAMMOSCAPE was filed by MeVis Medical Solutions AG, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on September 21, 2023, and it was registered by office on December 29, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on February 22, 2024. Change of name and professional address of the trademark registration was recorded on March 24, 2024.
Goods And Services
The mark was filed in class 9 with following description of goods:
Computer hardware and downloadable computer software for use in viewing, enhancing and manipulating of digital images of the human breast for diagnosis, screening for breast cancer, therapy treatment planning, and monitoring of such diseases
Downloadable computer software for use in x-ray imaging for medical, calibration, and quality control purposes
Downloadable computer software for use with medical treatment planning and medical decision support systems
Downloadable computer software for reading, processing, examining, interpreting and analyzing 2D and 3D images of the human breast acquired with medical imaging modalities including x-ray, ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET)
Downloadable computer software for reading, processing, examining, interpreting and analyzing radiological images, mammograms, and other medical digital images
Downloadable computer software using artificial intelligence (AI), machine learning, and deep learning for diagnosing breast cancer.
The mark was filed in class 10 with following description of goods:
Medical apparatus, namely, equipment for computer-assisted analysis of abnormalities in medical images, namely, x-rays and mammograms, ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and related operating software, sold as a unit
Mammography biopsy positioner sold as a component feature of a medical apparatus for use in performing mammograms
Diagnostic, testing and monitoring apparatus for medical use for breast cancer screening.
The mark was filed in class 42 with following description of goods:
Providing temporary use of non-downloadable software for use in viewing, enhancing and manipulating of digital images of the human breast for diagnosis, screening for breast cancer, therapy treatment planning, and monitoring of such diseases
Providing temporary use of non-downloadable software for use in x-ray imaging for medical, calibration, and quality control purposes
Providing temporary use of non-downloadable software for use with medical treatment planning and medical decision support systems
Providing temporary use of non-downloadable software for reading, processing, examining, interpreting and analyzing 2D and 3D images of the human breast acquired with medical imaging modalities including x-ray, ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET)
Providing temporary use of non-downloadable software for reading, processing, examining, interpreting and analyzing radiological images, mammograms, ultrasound images, magnetic resonance images (MRI), computed tomography (CT) scans, computer-aided designs (CAD), and secondary captures images
Providing temporary use of non-downloadable software using artificial intelligence (AI), machine learning, and deep learning for diagnosing breast cancer.